NovoCureの空売り状況は、投資家がNovoCureの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

NovoCure (NASDAQ:NVCR) 株価情報, 空売り情報

NovoCure

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

NovoCure Ltd

Inspirato (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(1.09) by 80.73 percent. This is a 93.44 percent increase over losses of $(3.20) per share from the same period last year. The company reported quarterly sales of $63.11 million which beat the analyst consensus estimate of $58.34 million by 8.18 percent. This is a 10.74 percent decrease over sales of $70.71 million the same period last year.

Earnings

Earnings Beats

News

ISPO

Inspirato Q4 EPS $(0.21) Beats $(1.09) Estimate, Sales $63.11M Beat $58.34M Estimate

Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) is looking for Q1 Adj EPS of $0.22-$0.42 vs $0.54 analyst estimate. sees sales of $505.000 million-$555.000 million vs $561.39 million analyst estimate.

Guidance

UCTT

Ultra Clean Hldgs Sees Q1 Adj EPS $0.22-$0.42 vs $0.54 Est; Sees Sales $505.000M-$555.000M vs $561.39M Est

Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.61) by 11.48 percent. This is a 1260 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $4.33 billion which missed the analyst consensus estimate of $4.43 billion by 2.34 percent. This is a 15.40 percent decrease over sales of $5.11 billion the same period last year.

Earnings Misses

Cleveland-Cliffs Q4 Adj $(0.68) Misses $(0.61) Estimate, Sales $4.33B Miss $4.43B Estimate

Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) co-founder and former CEO Steve Jobs would have turned 70 years old on Monday, Feb. 24. Apple fans and investors continue to pay premium prices at auctions for <a href="https://www.benzinga.com/markets/cryptocurrency/22/11/29682268/walk-a-mile-in-apple-founder-steve-jobs-shoes-literally-how-you-can-make-this-happen">memorabilia related to Jobs.</a>
What Happened: A rare signed business card of Jobs from 1983 recently<a href="https://www.benzinga.com/25/02/43755318/steve-jobs-signed-rare-apple-business-card-goes-up-for-auction-bids-touch-75000"> hit the auction block</a> as part of the Remarkable Rarities auction from RR Auction.
The business card <a href="https://www.rrauction.com/auctions/lot-detail/349802907124030-steve-jobs-signed-apple-business-card-c-1983-psa-gem-mt-10/">features </a>a Jobs autograph and is graded PSA 10 Gem Mint, the highest grade given by the well-known trading card and autograph authenticator.
Jobs&#8217;s role is listed as chairman and board of directors on the card, along with his name, Stephen Jobs. The business card features an address and telephone number for Apple and the company's rainbow version of the byte logo.
Ahead of the auction, RR Auctions stressed the rarity of the item. The auction house sold 15 Jobs business cards, but only four from the 1983 time period, including one that was signed.
RR Auctions estimated the Jobs business card at $60,000, but bidding quickly took the item over the $100,000 level before the auction ended. The business card sold for $103,750, including the buyer's premium.
Read Also: <a href="https://www.benzinga.com/general/education/24/10/41416276/warren-buffett-and-charlie-munger-signed-business-card-was-estimated-at-1-500-but-it-sold-for-a">Warren Buffett and Charlie Munger-Signed Business Card Was Estimated At $1,500 — But It Sold For A Lot More</a>
Why It's Important: Although the business card fetched a high price, making it one of the most expensive business cards sold at auction, it ranks only eighth among Jobs <a href="https://www.rrauction.com/search/?str=steve+jobs&amp;flexdatalist-str=steve+jobs&amp;type=t&amp;status=closed&amp;navsearch=true">memorabilia </a>auctioned by RR Auctions.
An Apple II manual signed and inscribed by Jobs sold for $787,484 by RR Auctions in August 2021. The business card is one of more than a dozen items from the former Apple CEO that have topped the $100,000 mark for the auction house.
Other auction houses have sold Steve Jobs memorabilia, including autographed items and artifacts from Apple&#8217;s early days.
Fractional investing company Rally <a href="https://www.benzinga.com/news/21/11/24343660/the-jacket-steve-jobs-wore-while-giving-middle-finger-to-ibm-logo-can-be-bought-for-7-50-a-share">previously offered shares</a> of an 86 Macintosh Plus signed by Jobs. The item was sold by Rally in September 2024 for $150,000. Rally currently <a href="https://app.rallyrd.com/app/assets/e2d46bd9-56c8-41b5-a056-380856b809d4/5f57debe-3ba9-4e1f-951c-ca4f2db8157d/view">offers </a>shares in the 1983 Steve Jobs iconic jacket, which he wore in a famous photo flipping off the IBM logo. The jacket is currently valued at $58,000.
The Jobs business card was the second most valuable item sold in the Remarkable Rarities Auction. A signed Albert Einstein iconic photo with his tongue out sold for $338,630, significantly higher than a $40,000 pre-auction estimate.
The auction also included signatures of historical figures like George Washington, King Henry VIII, The Beatles, Abraham Lincoln, Pablo Picasso, Benjamin Franklin and Winston Churchill.
A signed Elon Musk SpaceX replica helmet <a href="https://www.rrauction.com/auctions/lot-detail/349704307124029-elon-musk-signed-spacex-replica-helmet/">sold </a>for $21,655 in the auction, higher than a pre-auction estimate of $2,000.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/24/10/41196286/apple-founder-steve-jobs-swapped-porsches-every-6-months-heres-why">Apple Founder Steve Jobs Swapped Porsches Every 6 Months – Here&#8217;s Why</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

AAPL

Steve Jobs' Signed Apple Business Card, Valued At $60,000, Sells For Much More At Auction: Here's The Winning Bid

TREX

Trex Expects Q1 Revenues Of $325M - $330M (Est $324.118M), With Q2 Revenues To Be At Similar Levels To Last Year's, Followed By Very Strong YoY Comparisons In H2

Kingstone Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KINS#NASDAQ">KINS</a>) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.42 by 9.52 percent. This is a 206.67 percent increase over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $35.97 million which missed the analyst consensus estimate of $54.00 million by 33.39 percent. This is a 25.39 percent increase over sales of $28.68 million the same period last year.

KINS

Kingstone Companies Q4 Adj $0.46 Beats $0.42 Estimate, Sales $35.97M Miss $54.00M Estimate

The Social Security Administration is facing new uncertainties following the resignation of its acting commissioner. Michelle King stepped down after refusing to grant access to sensitive Social Security recipient information to the Department of Government Efficiency. Her departure has raised concerns among <a href="https://www.benzinga.com/personal-finance/25/02/43592816/social-security-beneficiaries-have-every-reason-to-be-alarmed-by-musks-access-to-u-s-department-of-treasury-payment-system">Social Security recipients</a> about the security of their personal data and the future of the program.
<h2 class="wp-block-heading">Leadership Shake-Up at SSA</h2>
<a href="https://www.benzinga.com/25/02/43773868/doge-demand-leads-to-resignation-of-acting-social-security-commissioner-trump-nominates-frank-bisignano-to-take-charge">King</a>, a longtime career official at the SSA, left her position on Feb. 17 after a dispute over DOGE's request for government records. According to media reports, King declined to provide DOGE staffers with access to detailed recipient information, prompting her departure.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
In response, the White House-appointed Leland Dudek, who previously worked in the agency's anti-fraud office, as the new acting commissioner. President Donald Trump has nominated Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>)&nbsp; Chairman Frank Bisignano to lead the SSA permanently, pending Senate confirmation.
<h2 class="wp-block-heading">What Is DOGE and Why Does It Want SSA Data?</h2>
DOGE has been at the center of controversy due to its aggressive push for access to federal databases, including those at the Treasury Department, Internal Revenue Service, and now the SSA. The group, which <a href="https://www.benzinga.com/personal-finance/25/02/43836529/elon-musks-social-security-warning-a-political-battle-over-billions-in-alleged-fraud">Elon Musk</a> has positioned as a cost-cutting and fraud-detection initiative, argues that accessing these records is necessary to eliminate waste and improper payments.
However, privacy advocates and former government officials warn that allowing DOGE access to such sensitive information could pose risks to beneficiaries. The <a href="https://www.ssa.gov/policy/docs/quickfacts/stat_snapshot/">SSA</a> holds data on more than 73 million people, including retirees, individuals receiving disability benefits, and those enrolled in Medicare. The information includes Social Security numbers, earnings records, and bank account details.&nbsp;
Trending: The average 401(k) balance soars to a record-breaking high – <a href="https://www.benzinga.com/money/average-401k-balances-soars-to-record-high">Here's how to know if your nest egg is keeping pace.</a>
Critics worry that improper access to these records could lead to errors, benefit disruptions, or even misuse of personal data. "There is no way to overstate how serious a breach this is," Nancy Altman, president of Social Security Works, an advocacy group for the preservation of Social Security benefits, <a href="https://apnews.com/article/social-security-elon-musk-doge-164c91f8477d5e7833af7f6de4bbde57">told the Associated Press</a>. "And my understanding is that it has already occurred."
<h2 class="wp-block-heading">Potential Impact on Social Security Beneficiaries</h2>
For those who rely on Social Security, this leadership shift and data controversy introduce several concerns:
<ul>
<li>Privacy Risks: The SSA has long maintained strict controls over beneficiary data. If DOGE is granted access, it raises questions about how securely this information will be handled.</li>
<li>Benefit Disruptions: Former SSA Commissioner Martin O&#8217;Malley told <a href="https://www.washingtonpost.com/politics/2025/02/17/doge-social-security-musk/">the Washington Post</a> that continued interference with agency operations could lead to interruptions in benefit payments.</li>
<li>Political Uncertainty: The future direction of <a href="https://www.benzinga.com/personal-finance/25/02/43831371/eliminating-social-security-income-taxes-would-cost-1-5-trillion-and-deplete-the-trust-fund-by-2032-who-wins-and-who-loses">Social Security policy</a> remains unclear as DOGE and the Trump administration advocate for greater transparency in federal spending while critics argue this could compromise program stability.</li>
</ul>
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
<h2 class="wp-block-heading">What Comes Next?</h2>
With Bisignano awaiting Senate confirmation, the SSA's future leadership remains uncertain. Meanwhile, watchdog groups and advocacy organizations, such as Social Security Works, continue to push for strict protections around beneficiary data.
For retirees and other Social Security recipients, the best course of action is to stay informed and monitor any potential changes to SSA policies. As the situation develops, beneficiaries should watch for official announcements regarding their benefits and personal data security.
For those concerned about their <a href="https://www.benzinga.com/personal-finance/25/02/43710578/your-benefits-have-been-suspended-some-americans-abroad-suddenly-lose-access-to-their-social-security-benefits">Social Security benefits</a> or personal data, experts recommend regularly checking account statements through the SSA's online portal and reporting any suspicious activity immediately.
Read Next:
<ul>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li><a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a></li>
</ul>

Personal Finance

Social Security In Uncertain Times: What The Resignation Of Michelle King And Musk's DOGE Data Push Could Mean For Beneficiaries

Contracts

Triumph Extends And Expands BAE M777 Lightweight Howitzer Program Role

PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) has outperformed the market over the past 10 years by 5.99% on an annualized basis producing an average annual return of 16.99%. Currently, PTC has a market capitalization of $19.56 billion. 
Buying $100 In PTC: If an investor had bought $100 of PTC stock 10 years ago, it would be worth $471.25 today based on a price of $162.58 for PTC at the time of writing.
<h3>PTC's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740432611_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In PTC 10 Years Ago Would Be Worth Today

Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.44 by 15.91 percent. This is a 168.42 percent increase over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $563.30 million which beat the analyst consensus estimate of $559.19 million by 0.73 percent. This is a 26.64 percent increase over sales of $444.80 million the same period last year.

Ultra Clean Hldgs Q4 Adj $0.51 Beats $0.44 Estimate, Sales $563.30M Beat $559.19M Estimate

WIIM

CHGG

Chegg shares are trading lower after the company issued Q1 sales guidance below estimates.

Adjusted EBITDA, which excludes one-time costs related to Arkansas start-up, digital transformation and the railing transition, is expected in the $378 million to $385 million range, inclusive of continued elevated investments in branding and product innovation. Adjusted EBITDA margin is expected to exceed 31%, consistent with 2024 despite the increased investment levels.

Trex Company Expects FY25 Net Sales To Range $1.21B - $1.23B,  Est $1.216B

DOMH

Dominari Holdings shares are trading higher after disclosing that Donald J. Trump Jr has reported a 6.71% stake in the company.

Hims &amp; Hers Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) reported its fourth-quarter results after Monday's closing bell. Here's a look at the key <a href="https://www.benzinga.com/pressreleases/25/02/b43925670/hims-hers-health-inc-reports-fourth-quarter-and-full-year-2024-financial-results">figures from the quarter. </a>
The Details: Hims &amp; Hers Health reported quarterly GAAP earnings of 11 cents per share, which met the analyst consensus estimate. Quarterly revenue came in at $481.14 million, which beat the analyst consensus estimate of $470.31 million and is an increase over revenue of $246.62 million from the same period last year.
Hims &amp; Hers subscribers grew to 2.2 million, up 45% year-over-year in 2024. Gross margin was 77% for the fourth quarter of 2024 compared to 83% for the fourth quarter of 2023.
Read Next: <a href="https://www.benzinga.com/general/market-summary/25/02/43920295/palantir-extends-losses-microsoft-slides-whats-driving-markets-monday">Palantir Extends Losses, Microsoft Slides: What&#8217;s Driving Markets Monday?&nbsp;</a>
&#8220;2024 was a fantastic year at Hims and Hers as we continue to build a platform that leverages personalization and technology unlike any traditional healthcare system,&#8221; said Andrew Dudum, Hims &amp; Hers Health CEO. 
&#8220;Over 2 million subscribers now entrust Hims &amp; Hers to aid them in their journey to better health — with thousands more joining daily,&#8221; Dudum added.
Outlook: For the first quarter of 2025, Hims and Hers expects revenue of $520 million to $540 million and adjusted EBITDA of $55 million to $65 million, reflecting an adjusted EBITDA margin of 11% to 12%.
For the full year 2025, the company expects revenue of $2.3 billion to $2.4 billion and adjusted EBITDA of $270 million to $320 million, reflecting an adjusted EBITDA margin of 12% to 13%.
HIMS Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Hims &amp; Hers Health shares are down 17.66% after hours at $42.25 Monday.  
Read Next:<a href="https://www.benzinga.com/government/regulations/25/02/43903335/financial-crime-weekly-1-4-billion-ethereum-stolen-in-largest-crypto-hack-ever-sec-creates-cyber-and-emerging-technologies-unit">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43903335/financial-crime-weekly-1-4-billion-ethereum-stolen-in-largest-crypto-hack-ever-sec-creates-cyber-and-emerging-technologies-unit">Financial Crime Weekly: $1.4 Billion Ethereum Stolen In Largest Crypto Hack Ever, SEC Creates Cyber And Emerging Technologies Unit</a></li>
</ul>
Image: Shutterstock

Health Care

Movers

General

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat

Primoris Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRIM#NASDAQ">PRIM</a>) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.75 by 32 percent. This is a 16.47 percent increase over earnings of $0.85 per share from the same period last year. The company reported quarterly sales of $1.70 billion which beat the analyst consensus estimate of $1.59 billion by 6.63 percent. This is a 12.14 percent increase over sales of $1.52 billion the same period last year.

PRIM

Primoris Services Q4 2024 Adj EPS $0.99 Beats $0.75 Estimate, Sales $1.70B Beat $1.59B Estimate

ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.17 by 111.76 percent. This is a 820 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $241.07 million which beat the analyst consensus estimate of $209.77 million by 14.92 percent. This is a 2.53 percent decrease over sales of $247.33 million the same period last year.

ProAssurance Q4 Adj EPS $0.36 Beats $0.17 Estimate, Sales $241.07M Beat $209.77M Estimate

WAFU

Wah Fu Education Group shares are trading higher after the company announced it will integrate DeepSeek to drive AI-based education innovation and long-term growth strategies.

Net income including noncontrolling interests midpoint of $3.45 billion, an 11% increase year-over-year.
"Looking ahead to 2026, we are excited about our position in the midstream value chain," the company said.
&nbsp;

ONEOK Expects FY25 EPS Midpoint Of $5.37, Est $6.03

Buybacks

ZION

Zions Bancorporation $40M Buyback

The market is coming off a relatively slow week and heading into what looks to be an eventful one. Stocks showed strength throughout the week but sold off sharply on Friday following a weaker consumer confidence report and growing fears of an economic slowdown due to tariffs and DOGE.
The spotlight this week is on NVIDIA, with $NVDA set to report earnings Wednesday after the bell. Investors aren't just looking for strong numbers—they'll be laser-focused on the company's guidance and Jensen Huang's outlook. Back in January, the release of China's DeepSeek large language model triggered a tech sell-off, sending Nvidia down 17% in a single session. Since then, sentiment has stabilized, but questions remain about the long-term impact on AI chip demand. Expect heightened volatility around the report, with guidance likely driving the stock's next big move.
Economic data was light last week, aside from Friday's disappointing consumer confidence report. This week, the main event is Core PCE, the Fed's preferred inflation measure, dropping Thursday morning. While I don't anticipate a major market shake-up, inflation has shown a persistent upward trend in recent CPI and PPI readings. Any upside surprise could keep rate-cut expectations in check.
With inflation fears bubbling up again, bearish sentiment has been creeping back into the market. Still, the S&amp;P 500 is holding onto a 2.46% gain year-to-date. Meanwhile, the 10-year Treasury yield has continued its decline, down roughly 8% since mid-January. In my view, lower yields are a tailwind for equities and should help support further upside.
Volatility is likely to stick around, and I wouldn't rule out a short-term pullback of around 5%. That said, I see any significant dip as a buying opportunity rather than a cause for concern.
My advice? Focus on the positive and keep an optimistic outlook.
&#x2A;&#x2A;
Welcome to the WOLF Financial Newsletter.
Join over 17,000 savvy investors building wealth and mastering advanced investing strategies live on Twitter Spaces. Subscribe below to be part of the action:
Subscribe
WOLF Financial has driven liquidity, user growth, and brand awareness across TradFi and Crypto through marketing, advisory, and partnership services. See more Here.
Disclaimer: Wolf Financial does NOT offer financial advice. All content provided is strictly for informational purposes. Wolf Financial is not registered as an investment, legal, or tax advisor, nor as a broker/dealer. Please be aware that trading any stock or crypto-related asset carries inherent risks and may lead to substantial capital losses.

Equities

Macro Economic Events

Broad U.S. Equity ETFs

Federal Reserve

Market-Moving Exclusives

Exclusives

Markets

NVDA

NVIDIA And Inflation Fears In This Week's Market Forecast

Press Releases

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors

Novocure Reports Third Quarter 2024 Financial Results

Novocure Appoints Christoph Brackmann as Chief Financial Officer

FDA Approves Novocure's Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma

Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma

Novocure to Participate in Upcoming Investor Conferences

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

Comments

NovoCure

空売り

NovoCure (NASDAQ:NVCR) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル